Reckitt Sales Hit by Lackluster US Demand for Cold Medicines
Reckitt Benckiser Group Plc reported weaker-than-expected sales on sluggish demand for its cold medicines in the US and as the conflict in the Middle East hit supplies in the region.
By · April 22, 2026 · 1 min read
This article was originally published by
Bloomberg Markets
and is republished here under license.
Reckitt Benckiser Group Plc reported weaker-than-expected sales on sluggish demand for its cold medicines in the US and as the conflict in the Middle East hit supplies in the region.
Patrick Brenner, CIO of multi-asset at Schroders, discusses earnings and equity markets. "Earnings have continued to deliver strongly," he tells Bloomberg…
Leave a Reply